Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers

被引:83
作者
Ebi, H. [1 ]
Sato, T. [1 ]
Sugito, N. [1 ]
Hosono, Y. [1 ]
Yatabe, Y. [2 ]
Matsuyama, Y. [1 ]
Yamaguchi, T. [1 ]
Osada, H. [3 ]
Suzuki, M. [1 ]
Takahashi, T. [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc,Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Aichi Canc Ctr Hosp, Dept Pathol & Mol Diag, Showa Ku, Nagoya, Aichi 464, Japan
[3] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Showa Ku, Nagoya, Aichi 464, Japan
基金
日本学术振兴会;
关键词
small-cell lung cancer; DNA damage response; miRNA; RB; reactive oxygen species; CHECKPOINT IMPAIRMENT; E2F1; IDENTIFICATION; EXPRESSION; MICRORNAS; APOPTOSIS; PATHWAY; DELETION; MIR-20A; CLUSTER;
D O I
10.1038/onc.2009.201
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small-cell lung cancer (SCLC) is a highly aggressive disease that exhibits rapid growth and genetic instability. We found earlier frequent overexpression of the miR-17-92 microRNA cluster, and showed that SCLC cells were addicted to continued expressions of miR-17-5p and miR-20a, major components of this microRNA cluster. In this study, we identified the frequent presence of constitutively phosphorylated H2AX (gamma-H2AX), which reflects continuing DNA damage, preferentially in SCLC. Knockdown of RB induced gamma-H2AX foci formation in non-small cell lung cancer (NSCLC) cells with wild-type RB, in association with growth inhibition and reactive oxygen species (ROS) generation, which was canceled by overexpression of miR-17-92. Conversely, induction of gamma-H2AX was observed in a miR-17-92-overexpressing SCLC cell line with miR-20a antisense oligonucleotides. These findings suggest that miR-17-92 overexpression may serve as a fine-tuning influence to counterbalance the generation of DNA damage in RB-inactivated SCLC cells, thus reducing excessive DNA damage to a tolerable level and consequently leading to genetic instability. Therefore, miR-17-92 may be an excellent therapeutic target candidate to elicit excessive DNA damage in combination with DNA-damaging chemotherapeutics. Oncogene (2009) 28, 3371-3379; doi: 10.1038/onc.2009.201; published online 13 July 2009
引用
收藏
页码:3371 / 3379
页数:9
相关论文
共 28 条
[1]   DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis [J].
Bartkova, J ;
Horejsi, Z ;
Koed, K ;
Krämer, A ;
Tort, F ;
Zieger, K ;
Guldberg, P ;
Sehested, M ;
Nesland, JM ;
Lukas, C ;
Orntoft, T ;
Lukas, J ;
Bartek, J .
NATURE, 2005, 434 (7035) :864-870
[2]   γ-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair [J].
Chowdhury, D ;
Keogh, MC ;
Ishii, H ;
Peterson, CL ;
Buratowski, S ;
Lieberman, J .
MOLECULAR CELL, 2005, 20 (05) :801-809
[3]   53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer [J].
DiTullio, RA ;
Mochan, TA ;
Venere, M ;
Bartkova, J ;
Sehested, M ;
Bartek, J ;
Halazonetis, TD .
NATURE CELL BIOLOGY, 2002, 4 (12) :998-1002
[4]   Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer [J].
Ebi, Hiromichi ;
Matsuo, Keitaro ;
Sugito, Nobuyoshi ;
Suzuki, Motoshi ;
Osada, Hirotaka ;
Tajima, Kazuo ;
Ueda, Ryuzo ;
Takahashi, Takashi .
CANCER RESEARCH, 2007, 67 (23) :11158-11165
[5]   Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions [J].
Gorgoulis, VG ;
Vassiliou, LVF ;
Karakaidos, P ;
Zacharatos, P ;
Kotsinas, A ;
Liloglou, T ;
Venere, M ;
DiTullio, RA ;
Kastrinakis, NG ;
Levy, B ;
Kletsas, D ;
Yoneta, A ;
Herlyn, M ;
Kittas, C ;
Halazonetis, TD .
NATURE, 2005, 434 (7035) :907-913
[6]   An oncogene-induced DNA damage model for cancer development [J].
Halazonetis, Thanos D. ;
Gorgoulis, Vassilis G. ;
Bartek, Jiri .
SCIENCE, 2008, 319 (5868) :1352-1355
[7]   A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation [J].
Hayashita, Y ;
Osada, H ;
Tatematsu, Y ;
Yamada, H ;
Yanagisawa, K ;
Tomida, S ;
Yatabe, Y ;
Kawahara, K ;
Sekido, Y ;
Takahashi, T .
CANCER RESEARCH, 2005, 65 (21) :9628-9632
[8]   MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes [J].
Inomata, Mika ;
Tagawa, Hiroyuki ;
Guo, Yong-Mei ;
Kameoka, Yoshihiro ;
Takahashi, Naoto ;
Sawada, Kenichi .
BLOOD, 2009, 113 (02) :396-402
[9]  
Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
[10]  
Konishi H, 2002, CANCER RES, V62, P271